Table 1.
Examples of common medications with anticholinergic properties in the elderly general population.
Fig 1.
Common anticholinergic adverse effects related to a growing anticholinergic burden.
Modified from Collamati et al. (2016).
Fig 2.
Concurrent health conditions superimposed on ID in descending order of prevalence.
Psychiatric disease: certified psychiatric comorbidity (e.g., psychosis, schizophrenia, autism spectrum disorder, personality disorder, depression); Neurologic disease: cerebral palsy, spina bifida, acute brain stroke, peripheral neuropathy, etc.; Neurocognitive disorder: primary or secondary neurocognitive disorders according to Silverman et al.’s classification [26]; Cardiovascular disease: heart diseases, hypertension, haematological and vascular diseases; Gastrointestinal disease: diseases both of the upper and inferior digestive tract.
Table 2.
Demographic, clinical and social characteristics by ACB score categories.
Table 3.
Multivariate analysis of significant factors associated with total ACB score 1–2 and ACB score 3+ (n = 98).
Table 4.
Study Comparisons on prevalent AC exposure in Italian cohorts.